Replimune Group Inc (REPL)
6.43
-0.29
(-4.32%)
USD |
NASDAQ |
May 17, 16:00
6.43
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Market Cap: 395.51M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 395.51M |
| May 16, 2024 | 412.71M |
| May 15, 2024 | 418.24M |
| May 14, 2024 | 412.10M |
| May 13, 2024 | 404.73M |
| May 10, 2024 | 393.50M |
| May 09, 2024 | 413.14M |
| May 08, 2024 | 410.07M |
| May 07, 2024 | 422.35M |
| May 06, 2024 | 430.33M |
| May 03, 2024 | 426.65M |
| May 02, 2024 | 402.70M |
| May 01, 2024 | 397.79M |
| April 30, 2024 | 389.81M |
| April 29, 2024 | 403.93M |
| April 26, 2024 | 394.11M |
| April 25, 2024 | 377.54M |
| April 24, 2024 | 388.58M |
| April 23, 2024 | 394.11M |
| April 22, 2024 | 394.11M |
| April 19, 2024 | 395.95M |
| April 18, 2024 | 427.87M |
| April 17, 2024 | 442.61M |
| April 16, 2024 | 438.92M |
| April 15, 2024 | 437.08M |
| Date | Value |
|---|---|
| April 12, 2024 | 438.31M |
| April 11, 2024 | 441.38M |
| April 10, 2024 | 427.26M |
| April 09, 2024 | 446.90M |
| April 08, 2024 | 437.08M |
| April 05, 2024 | 451.81M |
| April 04, 2024 | 450.59M |
| April 03, 2024 | 433.40M |
| April 02, 2024 | 437.70M |
| April 01, 2024 | 474.53M |
| March 28, 2024 | 501.54M |
| March 27, 2024 | 506.45M |
| March 26, 2024 | 472.07M |
| March 25, 2024 | 494.17M |
| March 22, 2024 | 503.38M |
| March 21, 2024 | 503.38M |
| March 20, 2024 | 497.86M |
| March 19, 2024 | 507.06M |
| March 18, 2024 | 508.29M |
| March 15, 2024 | 523.64M |
| March 14, 2024 | 542.67M |
| March 13, 2024 | 551.26M |
| March 12, 2024 | 534.07M |
| March 11, 2024 | 543.28M |
| March 08, 2024 | 554.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
316.98M
Minimum
Sep 03 2019
2.420B
Maximum
Dec 01 2020
1.002B
Average
935.73M
Median
Apr 05 2023
Market Cap Benchmarks
| Esperion Therapeutics Inc | 447.13M |
| Gossamer Bio Inc | 157.00M |
| NovaBay Pharmaceuticals Inc | 4.487M |
| Palatin Technologies Inc | 32.27M |
| iBio Inc | 6.899M |
Market Cap Related Metrics
| Price to Book Value | 1.056 |
| Price | 6.43 |
| Earnings Yield | -50.31% |